Hepatitis E virus in organ and cell donors
Part of Digestive system, Infections clinical trials.
This study looks for the hepatitis E virus in samples from people who are donating organs or cells. It helps us understand how common this virus is in donors and how to keep transplants safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are being considered to donate an organ or cells
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medication called AT-587 in healthy people to see if it is safe and how the body processes it. You may help by participating if you are in good health and meet the basic requirements.
This study tests a hepatitis E vaccine called Hecolin in healthy people (ages 2–45) and in adults (18–45) living with HIV who are on antiviral treatment. It aims to see how well the vaccine works and if it's safe for different groups.
This Phase 2 study tests the safety of Hecolin® (a hepatitis E vaccine) and how well it helps the body build protection in healthy pregnant women. You might be invited if you’re pregnant during specific weeks and healthy enough for vaccination and follow-up blood tests.
This Phase 2 trial tests giving newer hepatitis C medicines in a careful way to people getting a heart transplant who currently do not have hepatitis C in their blood. The goal is to lower hepatitis C infection risk from donated organs while keeping transplant outcomes safe.
This trial tests a new way to safely use donor lungs that carry the hepatitis B virus (HBV). It combines a special light treatment, ex-vivo lung perfusion (cleaning the lungs outside the body), and antiviral medicines to prevent infection in the recipient. If you are on the lung transplant list and have been vaccinated against hepatitis B, this study may help expand your donor options.
This trial is testing treatments for people with chronic hepatitis D, a serious liver infection. If you have antibodies to the hepatitis D virus (HDV), you may be able to join and help find better ways to manage this condition.
Hear when a new Hepatitis E trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.